Collignon Peter, Athukorala Prema-Chandra, Senanayake Sanjaya, Khan Fahad
ACT Pathology, Canberra Hospital, Australian National University, Garran, Australia; Canberra Clinical School, Australian National University, Garran, Australia.
Arndt-Corden Department of Economics, Australian National University, Acton, Australia; School of Environment and Development, University of Manchester, Manchester, England.
PLoS One. 2015 Mar 18;10(3):e0116746. doi: 10.1371/journal.pone.0116746. eCollection 2015.
To determine how important governmental, social, and economic factors are in driving antibiotic resistance compared to the factors usually considered the main driving factors-antibiotic usage and levels of economic development.
A retrospective multivariate analysis of the variation of antibiotic resistance in Europe in terms of human antibiotic usage, private health care expenditure, tertiary education, the level of economic advancement (per capita GDP), and quality of governance (corruption). The model was estimated using a panel data set involving 7 common human bloodstream isolates and covering 28 European countries for the period 1998-2010.
Only 28% of the total variation in antibiotic resistance among countries is attributable to variation in antibiotic usage. If time effects are included the explanatory power increases to 33%. However when the control of corruption indicator is included as an additional variable, 63% of the total variation in antibiotic resistance is now explained by the regression. The complete multivariate regression only accomplishes an additional 7% in terms of goodness of fit, indicating that corruption is the main socioeconomic factor that explains antibiotic resistance. The income level of a country appeared to have no effect on resistance rates in the multivariate analysis. The estimated impact of corruption was statistically significant (p< 0.01). The coefficient indicates that an improvement of one unit in the corruption indicator is associated with a reduction in antibiotic resistance by approximately 0.7 units. The estimated coefficient of private health expenditure showed that one unit reduction is associated with a 0.2 unit decrease in antibiotic resistance.
These findings support the hypothesis that poor governance and corruption contributes to levels of antibiotic resistance and correlate better than antibiotic usage volumes with resistance rates. We conclude that addressing corruption and improving governance will lead to a reduction in antibiotic resistance.
与通常被认为是主要驱动因素的抗生素使用和经济发展水平相比,确定政府、社会和经济因素在推动抗生素耐药性方面的重要程度。
对欧洲抗生素耐药性变化进行回顾性多变量分析,分析内容涉及人类抗生素使用、私人医疗保健支出、高等教育、经济发展水平(人均国内生产总值)和治理质量(腐败情况)。该模型使用一个面板数据集进行估计,该数据集涉及7种常见的人类血液分离菌,涵盖1998 - 2010年期间的28个欧洲国家。
各国抗生素耐药性总变异中只有28%可归因于抗生素使用的变异。如果纳入时间效应,解释力会增至33%。然而,当将腐败控制指标作为一个额外变量纳入时,抗生素耐药性总变异的63%现在可由回归模型解释。完整的多变量回归在拟合优度方面仅额外增加了7%,这表明腐败是解释抗生素耐药性的主要社会经济因素。在多变量分析中,一个国家的收入水平似乎对耐药率没有影响。腐败估计影响在统计学上具有显著性(p < 0.01)。该系数表明,腐败指标提高一个单位,抗生素耐药性会降低约0.7个单位。私人医疗支出的估计系数表明,支出减少一个单位,抗生素耐药性会降低0.2个单位。
这些发现支持了以下假设,即治理不善和腐败会导致抗生素耐药性水平上升,并且与耐药率的相关性比抗生素使用量更好。我们得出结论,解决腐败问题和改善治理将导致抗生素耐药性降低。